| Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study E Martinez, A Mocroft, MA García-Viejo, JB Pérez-Cuevas, JL Blanco, ... The Lancet 357 (9256), 592-598, 2001 | 564 | 2001 |
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients M Laguno, J Murillas, JL Blanco, E Martínez, R Miquel, ... Aids 18 (13), 27-36, 2004 | 511 | 2004 |
| COVID-19 in patients with HIV: clinical case series JL Blanco, J Ambrosioni, F Garcia, E Martínez, A Soriano, J Mallolas, ... The lancet. HIV 7 (5), e314, 2020 | 508 | 2020 |
| Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy E Martínez, JL Blanco, JA Arnaiz, JB Pérez-Cuevas, A Mocroft, A Cruceta, ... Aids 15 (10), 1261-1268, 2001 | 470 | 2001 |
| Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine E Martínez, I Conget, L Lozano, R Casamitjana, JM Gatell Aids 13 (7), 805-810, 1999 | 405 | 1999 |
| Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study J Del Amo, R Polo, S Moreno, A Díaz, E Martínez, JR Arribas, I Jarrín, ... Annals of internal medicine 173 (7), 536-541, 2020 | 389 | 2020 |
| Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection E Martínez, JA Arnaiz, D Podzamczer, D Dalmau, E Ribera, P Domingo, ... New England Journal of Medicine 349 (11), 1036-1046, 2003 | 388 | 2003 |
| Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachón, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 360 | 2020 |
| European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV* JD Lundgren, M Battegay, G Behrens, S De Wit, G Guaraldi, C Katlama, ... HIV medicine 9 (2), 72-81, 2008 | 283 | 2008 |
| Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count F García, E de Lazzari, M Plana, P Castro, G Mestre, M Nomdedeu, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 36 (2), 702-713, 2004 | 272 | 2004 |
| Continuous antiretroviral therapy decreases bone mineral density B Grund, G Peng, CL Gibert, JF Hoy, RL Isaksson, JC Shlay, E Martinez, ... Aids 23 (12), 1519-1529, 2009 | 268 | 2009 |
| Severe nucleoside-associated lactic acidosis in human immunodeficiency virus–infected patients: report of 12 cases and review of the literature V Falcó, D Rodríguez, E Ribera, E Martínez, JM Miró, P Domingo, ... Clinical infectious diseases 34 (6), 838-846, 2002 | 255 | 2002 |
| Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy A Suy, E Martínez, O Coll, M Lonca, M Palacio, E de Lazzari, M Larrousse, ... Aids 20 (1), 59-66, 2006 | 244 | 2006 |
| Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults MA Marcos, MTJ de Anta, JP de la Bellacasa, J González, E Martinez, ... European Respiratory Journal 21 (2), 209-214, 2003 | 241 | 2003 |
| Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study E Martinez, M Larrousse, JM Llibre, F Gutierrez, M Saumoy, A Antela, ... Aids 24 (11), 1697-1707, 2010 | 240 | 2010 |
| The role of viruses in the aetiology of community-acquired pneumonia in adults MA Marcos, M Camps, T Pumarola, JA Martinez, E Martinez, J Mensa, ... Antiviral therapy 11 (3), 351-359, 2006 | 217 | 2006 |
| High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors E Martínez, J Gatell, Y Morán, E Aznar, E Buira, A Guelar, J Mallolas, ... Clinical infectious diseases 27 (6), 1510-1513, 1998 | 193 | 1998 |
| Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy E Martínez, MA García-Viejo, JL Blanco, L Bianchi, E Buira, I Conget, ... Clinical infectious diseases 31 (5), 1266-1273, 2000 | 191 | 2000 |
| Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals O Miró, S López, E Martínez, E Pedrol, A Milinkovic, E Deig, G Garrabou, ... Clinical infectious diseases 39 (5), 710-716, 2004 | 179 | 2004 |
| A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis against Pneumocystis carinii Pneumonia after Highly Active Antiretroviral … JCLB de Quiros, JM Miro, JM Peña, D Podzamczer, JC Alberdi, ... New England Journal of Medicine 344 (3), 159-167, 2001 | 176* | 2001 |
